Search

Drugs commonly prescribed to treat high blood pressure do not worsen coronavirus (Covid-19) disease, according to research the BHF part-funded.

Our partnership with AliveCor means that £3 of every sale of their portable ECG will help fund our lifesaving research.

The journey from child to adult care is known as 'transition'. The experience of transition is different for every young person, we are here to help support you during this time.

An analysis and explainer of the excess deaths involving cardiovascular disease in England since the onset of the Covid-19 pandemic.

Want to make a healthy lifestyle change? We share five science-backed ways to help you change your habits.

Discover the devastating impact Covid-19 has had on cardiovascular care and what needs to be done to give all heart patients the support they need.

Over 500,000 people in the UK are living with heart failure. BHF research has created treatments to give people with heart failure longer, healthier lives.

The NHS in England will receive an extra £5.4billion over the next six months to help recover from Covid-19 and tackle long waiting lists, including for vital heart care. We are calling on the Treasury to commit to a clear recovery plan for cardiovascular care alongside a commitment to long-term investment in the NHS in the upcoming Comprehensive Spending Review.

Our partnership with Marks & Spencer has already generated £1m in donated stock. Find out more about our partnership and how we're working with Marks and Spencer to fund lifesaving research.